Results 11 to 20 of about 5,668,323 (316)

Hematopoietic Cell Transplantation for Lymphomas

Cancer Control, 2011
Background The heterogeneity of lymphomas results in numerous treatment options, including both autologous and allogeneic hematopoietic cell transplantation. However, the type of transplantation, the timing the procedure, and the selection of suitable patients for transplant continue to evolve.
Ernesto, Ayala, Marcie, Tomblyn
openaire   +3 more sources

APPENDICEAL DISEASE IN HEMATOPOIETIC CELL TRANSPLANTATION [PDF]

Clinical Case Reports, 2021
Appendiceal diseases are relatively rare reported complications during hematopoietic stem cell transplantation with no guidance on management. Pre- and post-transplant patients should receive a trial of medical therapy with appendectomy after recovery but prior to transplant in the former and plan for appendectomy after completion of immunosuppression ...
Zachary Wright, Francis Essien, John Renshaw, Michael Wiggins, Alexander Brown, Michael Osswald   +5 more
openaire   +4 more sources

Haploidentical hematopoietic cell transplantation [PDF]

Bone Marrow Transplantation, 2008
Haploidentical hematopoietic stem cell transplantation (HSCT) provides an opportunity for nearly all patients to benefit from HCT when a HLA genotypically matched sibling is not available. Initial results with the use of mismatched allografts led to limited enthusiasm due to GVHD and infectious complications resulting in unacceptable treatment-related ...
L-P, Koh, N, Chao
openaire   +2 more sources

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide [PDF]

, 2021
Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy.
Martino Bofarull, Rodrigo, Sierra, Jorge, Sánchez Ortega, Isabel, Esquirol, Albert, García Cadenas, Irene, Herruzo, Beatriz, Universitat Autònoma de Barcelona. Departament de Medicina, Pérez, Ariadna, Parody, Rocío, Sanchez-Ortega, Isabel, Garcia-Cadenas, Irene, Kwon, Mi, Hernani, Rafael, Pascual, Maria Jesús, Ferra, Christelle, Dorado, Nieves, Torrent, Anna, Dorado-Herrero, Nieves, Martino, Rodrigo, Spanish Group for Hematopoietic Stem cell Transplantation (GETH), Parody Porras, Rocío, Torrent Catarineu, Anna, Maria Jesús Pascual, Rafael Hernani, Mi kwon, Albert Esquirol, Irene Garcia Cadenas, Beatriz Herruzo, Isabel Sanchez-Ortega, Anna Torrent, Nieves Dorado, Christelle Ferra, Jorge Sierra, Rodrigo Martino, Ariadna Pérez, null null, Rocio Parody   +36 more
core   +1 more source

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study [PDF]

, 2013
Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.
Madrigal, Alejandro, Horowitz, Mary, Passweg, Jakob, Bouzas, Luis Fernando, Szer, Jeff, Niederwieser, Dietger, Gratwohl, Alois, Aljurf, Mahmoud, Iida, Minako, Kodera, Yoshihisa, Pasquini, Marcelo C., Marrow Transplantation,, Lipton, Jeff, Worldwide Network of Blood,, Gratwohl, Michael, Baldomero, Helen, Frauendorfer, Karl, Baldomero H, Niederwieser D, Horowitz M, Lipton J, Szer J, Kodera Y, Gratwohl M, Gratwohl A, Aljurf M, Iida M, Passweg J, Pasquini MC, Madrigal A, Bouzas LF, Frauendorfer K   +31 more
core   +1 more source

Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients [PDF]

, 2013
Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients
Lehrnbecher, Thomas, Thomas eLehrnbecher, Schmidt, Stanislaw, Thomas eKlingebiel, Tramsen, Lars, Lars eTramsen, Klingebiel, Thomas, Stanislaw eSchmidt, Stanislaw Schmidt, Lars Tramsen, Thomas Klingebiel, Thomas Lehrnbecher   +11 more
core   +1 more source

Hematopoietic chimerism after allogeneic stem cell transplantation : a comparison of quantitative analysis by automated DNA sizing and fluorescent in situ hybridization [PDF]

, 2005
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed mainly in patients with high-risk or advanced hematologic malignancies and congenital or acquired aplastic anemias.
Wachowiak, Jacek, Tomasz Strabel, Peter Bader, Bader, Peter, Jólkowska, Justyna, Jacek Wachowiak, Michał Witt, Anna Pieczonka, Strabel, Tomasz, Pieczonka, Anna, Dariusz Boruczkowski, Boruczkowski, Dariusz, Justyna Jółkowska, Witt, Michal   +13 more
core   +2 more sources

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor [PDF]

, 2013
Mobilized blood has supplanted bone marrow (BM) as the primary source of hematopoietic stem cells for autologous and allogeneic stem cell transplantation.
Dembowsky, K., Dembowsky, Klaus, Romagnoli, B., G Spohn, Karpova, Darja, Patel, K., Chevalier, E., Levesque, J. P., E Chevalier, D Karpova, Patel, Kalpana, Spohn, Gabriele, Romagnoli, Barbara, Schulz, M., Wiercinska, Eliza, Chevalier, Eric, H Bonig, K Dauber, E Wiercinska, J P Levesque, Schulz, Miriam, Chudziak, D., K Dembowsky, Dauber, Katrin, Karpova, D., B Romagnoli, A R Pettit, Wiercinska, E., D Chudziak, Levesque, Jean-Pierre, Bönig, Halvard-Björn, Spohn, G., Pettit, Allison R., M Schulz, K Patel, Bonig, H., Pettit, A. R., Chudziak, Doreen, Dauber, K.   +38 more
core   +1 more source

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [PDF]

, 2004
We report the outcomes after reduced-intensity conditioning allogeneic stem cell transplantation (RIT) for non-Hodgkin lymphoma (NHL) in 88 patients (low-grade NHL [LG-NHL], n = 41; high-grade NHL [HG-NHL], n = 37; mantle cell lymphoma [MCL], n = 10 ...
Mahendra, P, Smith, GM, Cook, G., Hatton, C., Tighe, J., Morris, E., Goldstone, A, Peggs, K., Cook, G, Mahendra, Premini, Hunter, A., Mackinnon, S, Milligan, D., Smith, G.M., Goldstone, A., Chopra, R, Hunter, A, Linch, D., Parker, A, Linch, D, Morris, E, Hunter, A.H., Milligan, D, Thomson, K, Parker, A., Peggs, K, Chopra, R., Thomson, K., Craddock, C., Hatton, C, Mackinnon, S., Milligan, Donald, Mahendra, P., Schey, S., Craddock, Charles; id_orcid, Craddock, C, Schey, S, Tighe, J   +37 more
core   +1 more source

Arrhythmias in the setting of hematopoietic cell transplants [PDF]

Bone Marrow Transplantation, 2015
Prior studies report that 9-27% of persons receiving a hematopoietic cell transplant develop arrhythmias, but the effect on outcomes is largely unknown. We reviewed data from 1177 consecutive patients ⩾40 years old receiving a hematopoietic cell transplant at one center during 1999-2009.
Tonorezos, Emily S., Stillwell, Elizabeth E., Calloway, James J., Glew, Timothy, Wessler, Jeffrey D., Rebolledo, Brian J., Pham, Anthony, Steingart, Richard M., Lazarus, Hillard, Gale, Robert P., Jakubowski, Ann A., Schaffer, Wendy L.   +11 more
openaire   +2 more sources